Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.4903
+0.0216 (4.60%)
At close: Dec 31, 2025
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $526.74 million as of December 31, 2025. Its market cap has increased by 0.12% in one year.
Market Cap
526.74M
Enterprise Value
506.42M
Revenue
122.89M
Ranking
n/a
PE Ratio
37.65
Stock Price
$0.49
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 526.74M, an increase of 5,401.06%. That is a compound annual growth rate of 15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 526.71M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Glass House Brands | 710.35M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 356.97M |
| CytoDyn | 355.55M |
| Silence Therapeutics | 287.18M |
| OpGen | 160.13M |